Memokath-051 stent for ureteric obstruction
In development [GID-MT569] Expected publication date: 07 December 2022
Search results
35 results
-
-
Sebelipase alfa for treating Wolman disease [ID3995]
In development [GID-HST10047] Expected publication date: TBC
-
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]
In development [GID-HST10037] Expected publication date: TBC
-
Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]
In development [GID-HST10004] Expected publication date: TBC
-
SpaceOAR hydrogel spacer for reducing rectal toxicity during radiotherapy for prostate cancer (Suspended – referred to technology appraisals)
In development [GID-MT526] Expected publication date: TBC
-
GID-MT567 Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain
In development [GID-MT567] Expected publication date: TBC
-
Skin abscess: antimicrobial prescribing
In development [GID-NG10163] Expected publication date: TBC
-
Conjunctivitis: antimicrobial prescribing
In development [GID-NG10166] Expected publication date: TBC
-
Blepharitis: antimicrobial prescribing
In development [GID-NG10168] Expected publication date: TBC
-
Stye: antimicrobial prescribing
In development [GID-NG10167] Expected publication date: TBC
-
Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]
In development [GID-HST10050] Expected publication date: TBC
-
GID-MT557 Novii Wireless Patch System for maternal and fetal monitoring (MT509)
In development [GID-MT557] Expected publication date: TBC
-
Setmelanotide for treating obesity caused by LEPR or POMC deficiency [ID3764]
In development [GID-HST10034] Expected publication date: 20 July 2022
-
Velmanase alfa for treating alpha-mannosidosis [ID800]
In development [GID-HST10010] Expected publication date: TBC
-
Eteplirsen for treating Duchenne muscular dystrophy [ID1003]
In development [GID-HST10007] Expected publication date: TBC
-
Peezy Midstream for urine collection (MT446)
In development [GID-MT538] Expected publication date: TBC
-
GID-MT568 Magtrace and Sentimag for locating sentinel lymph nodes
In development [GID-MT568] Expected publication date: 05 October 2022
-
GID-MT566 Faecal microbiota transplant for recurrent Clostridioides difficile infection
In development [GID-MT566] Expected publication date: 30 August 2022
-
Maralixibat for treating type 2 progressive familial intrahepatic cholestasis ID3818
In development [GID-HST10040] Expected publication date: TBC
-
Human alpha1-proteinase inhibitor for treating emphysema ID856
In development [GID-HST10017] Expected publication date: TBC
-
Afamelanotide for treating erythropoietic protoporphyria [ID927]
In development [GID-HST10009] Expected publication date: TBC
-
Palovarotene for treating flare ups of heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID2721]
In development [GID-HST10033] Expected publication date: TBC
-
GID-MT562 FibroScan for assessing liver fibrosis and cirrhosis in primary or community care
In development [GID-MT562] Expected publication date: 01 June 2022
-
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (review of HST3) ID1642
In development [GID-HST10044] Expected publication date: 25 January 2023
-
Lysosomal acid lipase deficiency - sebelipase alfa [ID737]
In development [GID-LYSOSOMALACIDLIPASEDEFICIENCYSEBELIPASEALFAID737] Expected publication date: TBC
-
Elivaldogene autotemcel for treating cerebral adrenoleukodystrophy [ID1284]
In development [GID-HST10038] Expected publication date: TBC
-
GID-MT563 NPi-200 for pupillary light reflex in critical care patients
In development [GID-MT563] Expected publication date: TBC
-
GID-MT570 AposHealth for osteoarthritis (OA) of the knee
In development [GID-MT570] Expected publication date: 31 March 2023
-
Social work with adults experiencing complex needs
In development [GID-NG10145] Expected publication date: TBC
-
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency [ID3791]
In development [GID-HST10052] Expected publication date: 29 March 2023
-
GID-MT564 GreenLight XPS for treating benign prostatic hyperplasia
In development [GID-MT564] Expected publication date: 14 October 2022
-
GID-MT565 Optilume for recurrent bulbar urethral strictures
In development [GID-MT565] Expected publication date: 28 November 2022
-
Advocacy services for adults with health and social care needs
In development [GID-NG10156] Expected publication date: 09 November 2022
-
GID-MT568 Magtrace and Sentimag for locating sentinel lymph nodes: draft guidance
We are listening to your views on this Medical technologies guidance. Comments close 16 June 2022.
-
Onasemnogene abeparvovec for treating spinal muscular atrophy (review of HST15) [ID4051]
In development [GID-HST10053] Expected publication date: TBC